Mainland Medical Company to be Listed on HK GEM

Home>>Business

Last updated at: (Beijing Time) Wednesday, July 31, 2002

Mainland Medical Company to be Listed on HK GEM

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced Tuesday its proposed listing on the Growth Enterprise Market (GEM) of the Stock Exchange of Hong Kong on August 13.

DISCUSSION

CHINESE

SEND TO FRIEND

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced Tuesday its proposed listing on the Growth Enterprise Market (GEM) of the Stock Exchange of Hong Kong on August 13.

According to Chairman Wang Haibo, the company will initially offer 198 million H shares (mainland shares listed in Hong Kong) for subscription by way of placing, of which 18 million H shares are to be converted from domestic shares. The offer price will be between 1.13 HK dollars and 1.40 HK dollars per H share.

Established in November 1996 in Shanghai's Pudong new district,Fudan-Zhangjiang is principally engaged in the research, development and production of bio-pharmaceutical products as well as in technological development.

Fudan-Zhangjiang's major strategic shareholders are Shanghai Pharmaceutical Co., Ltd., China General Technology Holdings Limited, Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. and Fudan University.

Questions?Comments? Click here

Renminbi Appeals Increasingly to Domestic Users: Statistics ( 8 Messages)

Institutional Guarantee for the Selection and Appointment of Capable People ( 2 Messages)

News Analysis: Why China Ranks Sixth in World Trade ( 3 Messages)

Missing Worker Found, Relatives Mourn ( 80 Messages)

China Protests over Falun Gong Resolution by US Congress ( 13 Messages)

Secret of China's Manned 'Spaceport' Revealed ( 98 Messages)